The treatment of Basal Joint Arthritis & Eye Health with vitamins

Basal Joint Arthritis and Eye Health: Mitamins custom make quality formulas for the treatment of Basal Joint Arthritis & Eye Health with vitamins. A Basal Joint Arthritis & Eye Health formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Basal Joint Arthritis and Eye Health

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Potassium
    100
    mg
    3%
    Omega - 3 Fatty Acids
    100
    mg
    *
    Lutein
    1000
    mcg
    *
    Chondroitin Sulfate
    200
    mg
    *
    Bilberry Extract
    50
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
  • Amount Per Serving
    % DV
    Feverfew Extract
    50
    mg
    *
    American Ginseng Extract
    100
    mg
    *
    Licorice Extract
    250
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    Ginger Extract
    100
    mg
    *
    White Willow Extract
    60
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Basal Joint Arthritis and Eye Health
Serving Size:4-5

Basal Joint Arthritis and Eye Health Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Abbott's HUMIRA® (Adalimumab) Approved In The European Union For The Treatment Of Crohn's Disease
Abbott announced today that it has received marketing authorization from the European Commission for the use of HUMIRA® (adalimumab) as a treatment for severe Crohn's disease. HUMIRA is the first self-administered biologic for the treatment of Crohn's disease and offers an effective and convenient treatment option that can help enable patients to maintain control of their disease.
Banded Treatment: Too Early To Assess Impact, Says BDA, UK
Commenting on the interim study - Dental Treatment Band Analysis, England 2007 - the Chair of the British Dental Association's General Dental Practice Committee, Dr Lester Ellman said: "Dentists and patients have been highly critical of the Government's changes to dentistry which brought in a crude, target driven system, untried and untested. This is a period of major transition and it's too early to say what the full impact of the new contract will be on treatment patterns.
This information concerning the support of Basal Joint Arthritis and Eye Health treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments